XML 42 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 29, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,229,778 $ 913,163
Marketable Securities, Current 0 689,916
Accounts receivable, net 602,141 632,811
Inventories, net 404,570 428,062
Other current assets 211,917 337,139
Total current assets 2,448,406 3,001,091
Property, plant and equipment, net:    
Property, plant and equipment, net 517,932 509,654
Operating Lease, Right-of-Use Asset 149,305 155,083
Intangible assets, net 2,763,211 3,022,321
Goodwill 6,558,660 6,533,550
Other assets, net 332,223 342,966
Total assets 12,769,737 13,564,665
Current liabilities:    
Current portion of long-term debt 1,045 721,872
Accounts payable 176,407 204,121
Accrued expenses and other current liabilities 510,488 524,470
Total current liabilities 687,940 1,450,463
Long-term debt 3,185,699 3,177,770
Deferred taxes and other long-term liabilities 845,998 930,946
Operating Lease, Liability, Noncurrent 128,399 132,747
Total liabilities 4,848,036 5,691,926
Commitments and contingencies (see Note 13)
Stockholders' equity:    
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding 0 0
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 122,091,000 shares and 123,426,000 shares at September 29, 2024 and December 31, 2023, respectively 122,091 123,426
Capital in excess of par value 2,272,405 2,416,793
Retained earnings 5,759,120 5,609,212
Accumulated other comprehensive loss (231,915) (276,692)
Total stockholders’ equity 7,921,701 7,872,739
Total liabilities and stockholders’ equity $ 12,769,737 $ 13,564,665